This bulletin appeared this a.m. on Stockwatch (address below)
FYI - the "Financial Post" is a business newspaper in Canada, "Griffiths McBurney" is a Vancouver investment house.
->Receptagen Ltd - In the News
->Post says biotech takeover activity heats up
->Receptagen Ltd RCG (Toronto Stock Exchange)
Shares issued 17,446,254 Dec 31 close $0.14
->Tue 31 Dec 96 In the News
The Financial Post reports in its Tuesday edition that when shares in Genetics Institute cease trading on Tuesday, as American Home Products buys the biotech company for US$1.2 billion, only one question will remain: who is next? Reporter Jennifer Lanthier says that a December 18 report by analysts at Boston's Cowen & Co called the Genetics Institute buyout good news for the sector, which underscores Cowen's "positive investment thesis" on biotechnology companies. Cowen's report recommends that investors make their picks based on strong fundamentals, including broad platform technologies, strong management, impressive market opportunities,smart commercialization strategies and good news flow. The main potential target in Canada is highly successful BioChem Pharma. Troubled biotechs with solid technology and attractively low share prices, such as Receptagen of Burnaby, BC, could also be targets, according to Griffiths McBurney analyst Bin Huang.
(c) Copyright 1997 Canjex Publishing Ltd.
canada-stockwatch.com
Checkout stockwatch - good historical price charts, bulletin summaries and company info.
Murray |
